Please assess the completion status of the following clinical trial:

Trial Title: Volume Restriction in Esophageal Carcinoma Surgery: Randomized Clinical Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* esophageal carcinoma~* Lewis Tanner procedure (median laparotomy and right thoracotomy)~Exclusion Criteria:~* younger than 18 years~* severe lung disease~* chronic renal insufficiency~* a physical status classification \> III on the American Society of Anesthesiologists (ASA) scale~* impossible to perform epidural catheter placement~* thoraco-phreno-laparotomy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Restrictive group (Type: ACTIVE_COMPARATOR): Patients who received ≤ 8ml/kg/h of intraoperative fluid. A fluid administered during surgery: Plasma-Lyte 148 (pH 7.4; Viaflo, Baxter, US), 10% Aminoven (Fresenius Kabi AG, Bad Homburg, Germany) at 0.5 ml/kg/h, 5 ml/kg of colloid (6% Voluven 130/0.4, Fresenius Kabi AG, Bad Homburg, Germany), packed red blood cells.
- Liberal group (Type: ACTIVE_COMPARATOR): Patients who received \> 8 ml/kg/h of fluid. A fluid used during surgery: Plasma-Lyte 148 (pH 7.4; Viaflo, Baxter, US), 10% Aminoven (Fresenius Kabi AG, Bad Homburg, Germany) at 0.5 ml/kg/h, 5 ml/kg of colloid (6% Voluven 130/0.4, Fresenius Kabi AG, Bad Homburg, Germany), packed red blood cells.

Based on this trial design, predict the completion outcome and termination type (if applicable).